Yesterday Medtronic (NYSE: MDT) held their annual analyst and investor day which of course included an overview and outlook for their diabetes franchise. While much was said the most telling fact to come out of the presentation was found on slide 16 which noted that the company’s market share from 2012 through 2018. A share which only once went below 60% (59% 2016) and now stands at 73%. The company also noted that while past year was filled with many challenges it still achieved record revenues.
For everything else that was said, more on that in a . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.